awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q46202919-EE153F98-F9F0-4195-91BC-E44D4BC14EB0
Q46202919-EE153F98-F9F0-4195-91BC-E44D4BC14EB0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q46202919-EE153F98-F9F0-4195-91BC-E44D4BC14EB0
Safety and Efficacy of Gevokizumab in Patients with Behçet's Disease Uveitis: Results of an Exploratory Phase 2 Study.
P2860
Q46202919-EE153F98-F9F0-4195-91BC-E44D4BC14EB0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q46202919-EE153F98-F9F0-4195-91BC-E44D4BC14EB0
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
cfa43b31b97d45a834b7b77a9f82f404cc77f276
P2860
Kinetic approach to pathway attenuation using XOMA 052, a regulatory therapeutic antibody that modulates interleukin-1beta activity.